title: [Bilateral acute depigmentation of the iris syndrome].
abstract: Bilateral acute depigmentation of the iris syndrome (BADI syndrome) is a new clinical entity. Young females from 20 to 45 years of age are most commonly affected. It is characterized by bilateral nontransilluminating depigmentation of the iris stroma. During the acute phase, this clinical entity also combines with red painful eye, pigmentation of the trabecular meshwork, anterior chamber flare, circulating pigment, and pigmented deposit on the endothelium cornea. At the acute stage, the symptoms are controlled with topical corticosteroid treatment. The prognosis is good. We report a 41-year-old woman presenting with BADI syndrome.
authors.affiliation: Service d'ophtalmologie, hôpital Charles-Nicolle, 1, rue de Germont, 76031 Rouen cedex, France.
authors.forename: A
authors.initials: A
authors.lastname: Portmann
authors.forename: J
authors.initials: J
authors.lastname: Gueudry
authors.forename: K
authors.initials: K
authors.lastname: Siahmed
authors.forename: M
authors.initials: M
authors.lastname: Muraine
mesh_terms: D000208:Acute Disease; D000328:Adult; D003907:Dexamethasone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005127:Eye Color; D058447:Eye Pain / Q000209:etiology; D005260:Female; D006801:Humans; D007499:Iris Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D010859:Pigmentation Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D013577:Syndrome; D014031:Tobramycin / Q000627:therapeutic use; D014605:Uveitis / Q000175:diagnosis
chemical_list: D003907:Dexamethasone; D014031:Tobramycin